Physician profile
Emily Hall
NPI 1427727965
$738.17
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $234 · 2023: $384 · 2024: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.01 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $241.07 | 2022-2023 | |
| Harmony Biosciences LLC | $96.98 | 2022-2024 | Wakix |
| Glaxosmithkline, LLC. | $92.18 | 2022-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Aadi Bioscience, INC. | $87.87 | 2024 | Fyarro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.51 | 2023-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $50.92 | 2023 | Tezspire, Breztri |
| Philips North America LLC | $49.46 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $21.32 | 2023 | Opsumit, Uptravi |
| Grifols USA, LLC | $18.86 | 2023 | Xembify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.